Dr. Malek Mushref, MD

Dr. Mushref practices at Athens Surgery Center LLC in Athens, Georgia.

Dr. Mushref's NPI, 1619339124, was assigned on March 23, 2016. Dr. Mushref holds Georgia license 88454.

Dr. Mushref's primary practice is Athens Surgery Center LLC, at 1500 Oglethorpe Ave, Athens, GA 30606 in Clarke County. The practice phone is (678) 971-4227.

Dr. Mushref's primary practice is Athens Surgery Center LLC in Athens, Georgia. Dr. Mushref is also affiliated with Piedmont Athens Regional. The medical group on file is Piedmont Physicians Obstetrics and Gynecology of Jasper. Dmand AI also links Dr. Mushref to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mushref practices, 5 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Mushref's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Mushref is licensed in Georgia.

CMS data shows 1,084 Medicare services from Dr. Mushref across 8 procedure codes in 2024, for 307 Medicare patients. Medicare paid $53,703 for them. Every service was in an office.

CMS counts 307 Medicare patients who saw Dr. Mushref in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mushref's median patient age at 61, with 65% women.

In 2024, Dr. Mushref wrote 2,999 Medicare Part D claims for 490 patients. 31% of them were for generic drugs. CMS names the drug for 2,631 of them, across 49 drugs with 11 or more claims each, at $1,783,916 in total drug cost. In 2023, CMS named 2,170 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Mushref for performance year 2024, reported through an alternative payment model (APM). Dr. Mushref accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mushref as offering telehealth.

Dmand AI links 3 papers to Dr. Mushref, published from 2015 to 2016. 2015 was the busiest year, with 2. The most frequent topics are Apoptosis and Macrophage Activation. Dr. Mushref's most frequent co-authors are Harmeet Malhi, MBBS, Gregory J. Gores, MD and Patrick S. Kamath, MD.

CMS Open Payments shows 116 general payments to Dr. Mushref from 21 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 59% of the total. Sanofi and Genzyme US Companies paid the most, $5,376.